Accelus Secures New Growth Financing To Support Continued Commercial Expansion and Pipeline Innovation
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Accelus, a privately held medical technology company focused on expandable spinal implant technologies, has closed a new equity financing round led by Concord Health Partners. The funding will support the company’s continued commercial growth and further development of its spinal implant technologies.
In conjunction with the financing, industry veteran Bernie Haffey has been appointed Chairman of the Accelus Board of Directors. Haffey brings over 20 years of experience in the medtech and healthcare sectors, having founded Haffey&Co, a strategic business management consultancy firm. He has previously served as President & CEO of two medtech start-ups, Nexis Vision Inc and NDO Surgical.
“The continued support from our partners through this latest equity financing round reinforces our long-term vision to bring meaningful innovation to spine care,” said Kevin McGann, President and CEO of Accelus. “We are now well positioned to deepen our U.S. market presence and invest in future pipeline innovations.”
Accelus’s product portfolio includes the FlareHawk® Interbody Fusion System, LineSider® Spinal System, and Toro-L® Interbody Fusion System. These products support minimally invasive techniques suitable for both hospital and ambulatory surgery center environments.
The additional funding will enable Accelus to expand its reach and continue building momentum as it grows its FlareHawk and Toro portfolios. “I am delighted to take this new role as Chairman of the Accelus Board at an important time in the Company’s evolution,” said Haffey. “I look forward to working with Kevin and the rest of the Accelus team to drive continued growth.”
About Accelus Accelus is a worldwide leader in expandable spinal implant technology, dedicated to enhancing surgical procedures and patient outcomes through innovative spinal solutions.
About Concord Health Partners Concord Health Partners is a healthcare-focused investment firm that optimizes the alignment of interests between investors and portfolio companies. For more information, visit www.concordhp.com.
